Skip to search formSkip to main contentSkip to account menu

Hemophan

Known as: Hemophane 
National Institutes of Health

Related topics

Related topics

3 relations

Broader (2)

BiomaterialsCellulose
analogs & derivatives

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2008
2008
Improved biocompatibility by modified cellulosic membranes: the case of hemophan.
The rising problem of biocompatibility is encouraging the development of new dialysis membranes, but the high cost of synthetic… 
2001
2001
Selective sequestration of cytokine-producing monocytes during hemodialysis treatment.
1995
1995
Relationship between reduction of complement activation by polysaccharide surfaces bearing diethylaminoethyl groups and their degree of substitution.
1994
1994
Acute symptoms during and between hemodialysis: the relative role of speed, duration, and biocompatibility of dialysis.
The relationship between hemodialysis (HD) symptoms and dialyzer membrane composition and area, blood-flow, treatment duration… 
1994
1994
Studies of biocompatibility of different dialyzer membranes: role of complement system, intracellular calcium and inositol-triphosphate.
PMNLs are activated during extracorporeal circulation. The aim of this cross-over biocompatibility study was to investigate the… 
Highly Cited
1992
Highly Cited
1992
Mobilization of an intracellular glycoprotein (Mac-1) on monocytes and granulocytes during hemodialysis.
We studied the upregulation of the intracellular glycoprotein Mac-1 (CD11b/CD18, CR3) on monocytes and granulocytes during 36… 
1990
1990
Intradialytic body weight changes and dialyzer pore size as main contributing factors to the evolution of beta-2-microglobulin in dialysis.
Cuprophane hemodialysis is associated with an early fall of leukocyte counts and an intradialytic rise in serum beta 2… 
Highly Cited
1989
Highly Cited
1989
Hemodialysis-related induction of beta-2-microglobulin and interleukin-1 synthesis and release by mononuclear phagocytes.
We have investigated beta 2-microglobulin (beta 2M) synthesis and release by blood leukocytes and isolated mononuclear phagocytes… 
1988
1988
Beta-2-microglobulin in hemodialysis patients. Effects of different dialyzers and different dialysis procedures.
beta 2-Microglobulin (beta 2m) has been identified as the major constituent of dialysis-related amyloid. Although there is no… 
1987
1987
Enhanced biocompatibility with a new cellulosic membrane: Cuprophan versus Hemophan.
Recently, a new type of modified cellulosic membrane (Hemophan) has been made available for the first clinical trials. In… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)